HIV Populations
Antiretroviral Combos with Nevirapine Better Prevent Mother-to-Child HIV Transmission
- Details
- Category: Pregnancy & HIV MTCT
- Published on Monday, 06 February 2012 22:00
- Written by Press Release
Regimens containing 2 or 3 antiretroviral drugs, including nevirapine (Viramune), were more effective than zidovudine (AZT; Retrovir) monotherapy at preventing viral transmission to babies born to HV positive mothers who did not received treatment during pregnancy and delivery, according to a report in the June 21, 2012, New England Journal of Medicine.
Pets and Parenthood Help Women Cope with HIV
- Details
- Category: Women & HIV
- Published on Friday, 27 January 2012 00:00
- Written by Liz Highleyman
Identification with their role as a mother, grandmother, or pet owner helped women with HIV cope with having a chronic disease, according to a study published in the January 2012 online edition of Women's Health Issues.
UPCOMING 1/25/12: Administration on Aging 'Graying of HIV/AIDS' Webinar
- Details
- Category: HIV & Aging
- Published on Tuesday, 24 January 2012 00:00
- Written by AIDSInfo/DHHS
The U.S. Administration on Aging (AoA) will host a free webinar entitled “The Graying of HIV/AIDS: Community Resources for the Aging Services Network” on Wednesday, January 25, from 2:00 to 3:00 pm Eastern Standard Time.
Nevirapine for 6 Months during Breast-feeding Prevents Perinatal HIV Transmission
- Details
- Category: Pregnancy & HIV MTCT
- Published on Tuesday, 24 January 2012 00:00
- Written by Liz Highleyman
Treating babies with nevirapine (Viramune) for 6 months while breast-feeding significantly reduced the risk of mother-to-child HIV transmission, though it did not alter the likelihood of infant mortality, according to a study of HIV positive African women and their babies described in the January 21, 2012, issue of The Lancet.
Pediatric Dose Recommendations for Darunavir (Prezista) and Raltegravir (Isentress)
- Details
- Category: Children & Adolescents
- Published on Tuesday, 27 December 2011 00:00
- Written by Press Release
The U.S. Food and Drug Administration (FDA) recently announced the approval of new dose recommendations and easy-to-use formulations of 2 antiretroviral drugs for children with HIV.
Web Design and Development by